Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.80
+0.01 (0.05%)
Jan 16, 2026, 4:00 PM EST - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.7 billion as of January 16, 2026. Its market cap has increased by 97.95% in one year.
Market Cap
2.70B
Enterprise Value
1.99B
1-Year Change
97.95%
Ranking
Category
Stock Price
$21.80
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.70B, an increase of 282.85%. That is a compound annual growth rate of 18.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.70B | -8.52% |
| Dec 31, 2025 | 2.95B | 116.38% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 938.32B |
| Johnson & Johnson | 526.43B |
| AbbVie | 379.23B |
| UnitedHealth Group | 301.83B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 271.63B |
| Novo Nordisk | 252.12B |